Inventor

Wenyuan Qian

Inventor
Camarillo, CA, US

Overview

22→
Patents
2008–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 22 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07DHeterocyclic compounds38%
A61KPreparations for medical, dental or toiletry purposes17%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
C07CAcyclic or carbocyclic compounds2%
C09BOrganic dyes or closely-related compounds for producing dyes, e.g. pigments2%
PatentTitleYear
11,021,4931,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of use202110,508,103Benzimidazole-linked indole compound acting as novel divalent IAP antagonist201910,246,429Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use20199,663,476'Glycine transporter-1 inhibitors'20179,611,261'Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use'20179,550,762'Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use'20179,493,459'Azetidine and piperidine compounds useful as PDE10 inhibitors'20169,303,028'Azetidine and piperidine compounds useful as PDE10 inhibitors'20169,296,734'Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use'20169,174,992'Heterobicyclic compounds'20159,085,576'Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use'20158,883,782'Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of use'20148,735,383'Glycine transporter-1 inhibitors'20148,691,986'Azetidine and piperidine compounds useful as PDE10 inhibitors'20148,426,447'Spiro-tricyclic ring compounds as beta-secretase modulators and methods of use'20138,258,306'Glycine transporter-1 inhibitors'20128,183,244'Glycine transporter-1 inhibitors'20127,662,811'1,2,3,4-tetrahydropyrazin-2-yl acetamides and methods of use'20107,612,060'Triazoles and methods of use'20097,538,114'Glycine transporter-1 inhibitors'20097,425,631'Compounds and methods of use'20087,393,852'Piperazine derivatives and methods of use'2008

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2008–2021Patents assigned to AMGEN INC (21)· patent assignee history
2008–2015Based in Camarillo, CA, US· patent location history
2012–2014Patents assigned to AMEGADZIE ALBERT (5)· patent assignee history
2012–2014Patents assigned to QIAN WENYUAN (5)· patent assignee history
2013–2014Patents assigned to CHENG ALAN C (2)· patent assignee history
2013–2014Patents assigned to DINEEN THOMAS (2)· patent assignee history
2014–2017Based in Newbury Park, CA, US· patent location history
2017–2021Based in Thousand Oaks, CA, US· patent location history
2019Based in Shanghai, CN· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
AMGEN INC212008–2021
AMEGADZIE ALBERT52012–2014
QIAN WENYUANself52012–2014
CHENG ALAN C22013–2014
DINEEN THOMAS22013–2014
Locations
LocationPatentsSpan
Camarillo, California, US112008–2015
Newbury Park, California, US72014–2017
Thousand Oaks, California, US32017–2021
Shanghai, CN12019